News

Dec 3, 2019

3 Named Fellows of Inventors Academy

NC State innovators in the fields of food safety and computer networking are recognized by the National Academy of Inventors.

Nov 8, 2019

NC State Awards 2019 Innovator & Entrepreneur of the Year

NC State strives to attract top-notch talent to our university. And the driven, dedicated people here consistently turn NC State research into real-world results, launching startups and patenting technologies at a record…

Jun 4, 2019

NIRSleep — a startup led by an NC State alumnus, former employee — wins $25,000 in 2019 Lulu eGames

Less than four years ago, Casey Boutwell was a licensing associate for the Office of Research Commercialization, helping NC State faculty take their research from the lab into the marketplace. Now, he’s…

Apr 4, 2019

NIRvana Sciences Awarded $3 Million Phase IIb SBIR Grant from NIH

NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins, today announced that it has been awarded a $3 Million Phase IIb SBIR grant from the National Institute of…

Feb 11, 2019

NC State Spinout Locus Biosciences Inks Historic Licensing Deal

NC State provides innovators with a range of programs and services to develop, protect, market and commercialize inventions developed at the university through the licensing of intellectual property or the launch…

Jan 11, 2019

Howling Cow Ice Cream Available in Harris Teeter Stores

A State Fair and NC State campus delectable treat is now available for the first time in grocery retail locations across parts of the Triangle. Six different flavors of Howling Cow®…

Jan 3, 2019

Locus Biosciences Enters a Collaboration and License Agreement with Johnson & Johnson Innovation to develop CRISPR-Cas3 Bacteriophage Therapeutics

Locus Biosciences Inc., a biotechnology company developing precision antibacterial therapies, announced today that it has entered into an exclusive collaboration and license agreement with Janssen Pharmaceuticals, Inc. (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to develop, manufacture and commercialize CRISPR-Cas3-enhanced bacteriophage ("crPhage™") products targeting two key bacterial pathogens for the potential treatment of infections of the respiratory tract and other organ systems.  Johnson & Johnson Innovation LLC facilitated the transaction.

Dec 12, 2018

Rebar to Retire From Office of Research and Innovation

Leadership of NC State’s research enterprise will shift at the start of the new year as Alan Rebar retires and Mladen Vouk takes the helm.

Nov 28, 2018

Partner Profile: BRI Taps NC State Talent and Technology

Partnerships with NC State University’s research and academic programs have played a role in BioResource International’s success from the company’s start nearly 20 years ago – and they will in the future, as well.

Aug 16, 2018

Meet the 2019 Chancellor’s Innovation Fund Recipients

Groundbreaking research happens every day at NC State, and a growing number of important technologies are making the leap from lab to marketplace. It’s no surprise that adequate funding is crucial to this transition.